Sanofi India share price gained up to 6% in morning trades on Friday post Q4 results announced by the company after the ...
Novavax, Inc. faces declining revenues and high risks despite the Sanofi deal and cost-cutting measures. Click here for my ...
With a market valuation of Rs 11,574.76 Cr, Sanofi Indias shares ended Fridays trading session on the BSE 0.58% higher at Rs ...
KYMR reports a wider-than-expected loss for the fourth quarter of 2024. The company expects the current cash balance to provide a runway into mid-2027.
Despite a significant increase in revenue, Cytokinetics Inc (CYTK) faces challenges with growing expenses and strategic ...
13hon MSN
Gain insights into Recursion Pharmaceuticals' Q4 2024 earnings call. Discover clinical advancements, key partnerships, and strategic plans for 2025.
The equity market witnessed a sharp decline today, with both benchmark indices dropping over 1%. By noon, the Sensex tumbled ...
DIsney says it has sold out all commercial inventory for Sunday's Oscars, and notes packages include TV, streaming, social ...
The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors ...
There could be continued earnings momentum in railway, infrastructure and capital good stocks but outlook on new orders could ...
Multibagger stock Vantage Knowledge Academy Limited hits upper circuit after setting record date for 2:1 bonus shares. The ...
Reported promising safety and preliminary efficacy data for REC-617, an oral CDK7 inhibitor, and met primary endpoints and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results